Issue link: https://nebusinessmedia.uberflip.com/i/1535835
26 HARTFORDBUSINESS.COM | JUNE 2, 2025 Opinion & Commentary Biz Starts 5 Sr Actuarial Analyst - Global Atlantic Financial Company - Hartford, CT. Actuarial assistant role responsible for providing math/quantitative analysis & support to credentialed Actuaries, incl generating analytics to be used in dvlpg & pricing new annuity products w/ objective of achieving sustainable competitive advantage w/ industry leading product portfolio. REQ'MTS: Bach (US or foreign equiv) in Actuarial Sci, Math or rel quantitative field +1 yr exp as Annuity Analyst or rel role. 1 yr exp must incl: Using Actuarial methods to design & model Annuity Products. Analysis of cash flow projections & profitability metrics. Using Stat methods & hypothesis testing for Risk Analysis. Enhancing fin'l reporting techniques using Microsoft Excel, Macros & VBA. Calculating capital req'mts & reserves while being mkt competitive. Candidates must have passed at least 2 actuarial examinations admin by Society of Actuaries. Expected annual base sal for Hartford, CT, US-based position is $62,500-$109,450. Please email resumes to Immigration@gafg.com. Please specifically incl ref code C# 8289341" in subject line of email when applying. EEO/AAE/V/D. OTHER VOICES BioCT CEO: Proposed prescription drug price controls would disincentivize life sciences industry growth in CT By Jodie Gillon A s the CEO of BioCT, I have the privilege every day of advancing and promoting Connecticut's vibrant life sciences industry. A core part of our mission is to enable talent and companies to come, stay here and grow here. Connecticut's life sciences sector includes approximately 1,500 companies and employs 25,000 people in high- quality, high-paying jobs. The innovation triangle between Stamford, Hartford and Groton is sought after by both employers and employees. New Haven, in fact, is ranked No. 9 in the nation for life science industry growth. Our state is home to some of the biggest names in the pharma- ceutical industry, along with small startups, tech innovators, major service providers, and world-class colleges and universities where life-saving research often begins. Research and development in Groton played a key role in creating the COVID vaccine. Spevigo, a lifesaving rare-disease therapy that won the Prix Galien — the Nobel Prize of drug development — was developed right here in Ridgefield. What we research, develop and manufacture in Connecticut saves the lives of those afflicted with devas- tating, often deadly diseases around the world. The talent we recruit and nurture here uses their superpowers not only to save lives but also to train the next gener- ation, from kindergarten through the doctoral level. This includes countless hours of programming, mentoring and internships that prepare future leaders. We all share a common goal: ensuring patients have access to the life-saving therapies they need. To do that, we must not only develop these therapies, but we must work together to provide a policy environment that directly supports patients without harming industry and rewarding middlemen. Our lawmakers clearly understand the value that our industry brings to Connecticut. Earlier this year at our legislative breakfast, Gov. Ned Lamont announced a proposal to increase the life science industry's tax credit from 65% to 90%. This would allow us to compete more effectively with our neighboring states. However, this critical industry could be decimated if some well-intended, but potentially damaging legislation is allowed to pass this session. House bill 6870, "An Act Addressing Patients' Prescription Drug Costs," could jeopardize the future of Connecti- cut's life science industry, and the treatments and cures it delivers here and around the world. Connecticut residents must have access to affordable testing and medi- cines, but this bill is not the solution. I urge legislators not to put forth a bill that would have no real benefit for patients, and which will make Connecticut one of the most restrictive states for life sciences companies, harming innovation and disincentiv- izing our industry from operating here. HB 6870 seeks to establish prescrip- tion drug price controls tied to the Consumer Price Index. Policies like these jeopardize patient access to life-saving medications and deter investment in biotechnology and future innovation. The bill would undermine the prog- ress Connecticut has made in building a thriving life sciences ecosystem by creating a negative regulatory environ- ment for the very businesses we are trying to retain and attract. We understand the pressure our legislators are under to lower health- care costs, but we urge careful, thoughtful action that considers models from other states that have found a balance between supporting patients and fostering innovation. We ask the legislature to partner with BioCT and other organizations to devise a better solution. As a starting point, lawmakers should examine the real cost drivers of medications: phar- macy benefit managers (PBMs). These companies make billions of dollars using complex and ever- changing policies that keep savings intended for patients, for themselves to increase their own bottom lines. In this time of national supply chain uncertainty, rising costs, economic volatility and intense federal fiscal and policy pressure, we need state support more than ever. HB 6870 would undo years of prog- ress in building a thriving life sciences industry, while failing to achieve its goal of benefitting patients. Jodie Gillon is the president and CEO of BioCT, a trade group that represents the state's life sciences industry. Jodie Gillon DOMIRRIQUENO RESTAURANT LLC 704 PARK STREET HARTFORD DOMIRRIQUENORESTAURANTLLC@GMAIL.COM PARKDALE LLC 581 FARMINGTON AVE HARTFORD JOHNPSOUZA88@AOL.COM OASIS VAPES LLC 869 NEW BRITAIN AVE HARTFORD ZAHIDC1@OUTLOOK.COM BIGGER 1'Z LLC 1988 MAIN ST HARTFORD TDAVON54@GMAIL.COM HINOSTROZA VENTURES LLC 670 FRANKLIN AVE HARTFORD JHINOSTROZA1123@GMAIL.COM HAILE FITNESS LLC 89 CAMPFIELD AVE HARTFORD HAILEFITNESS@YAHOO.COM ED FLOORING LLC 90 MAPLETON ST HARTFORD FLOORINGED25@GMAIL.COM LAURA CLEANING SERVICES LLC 118 SHULTAS PL HARTFORD LAURASERVICES25@GMAIL.COM KMC INOVATIONS LLC 36 RUSS STREET , 3RD FLOOR #1200 HARTFORD EFILE1234@INCFILE.COM PRICIS CLEANING TEAM INC 71 NATICK ST HARTFORD TASKPK2020@GMAIL.COM CAZI SERVICES LLC 8 ORANGE ST HARTFORD REFLEXBOX@GMAIL.COM LUXE LOUNGE & DETAILING LLC 496 PARK ST HARTFORD LUXELOUNGEANDDETAILING@GMAIL.COM KAJAH TRUCKING LLC 221 GRANDVIEW TER HARTFORD KAJAHAMABULLOCK@GMAIL.COM PASSION FRUIT PARADISE ESTHETICS LLC 10 FREDERICK ST HARTFORD PFPCOSMETICS@GMAIL.COM NEWBURY HEALTH LLC 48 FAIRFIELD AVE HARTFORD ALTINAPINA@GMAIL.COM COZY SHIELD LLC 42 HARWICH ST HARTFORD COZYSHIELDCT@GMAIL.COM THE PARRY�S PROPERTY LLC 78–80 SISSON AVE HARTFORD SASH.HH@LIVE.COM DAGOODCHEFBOWLS&WRAPS LLC 23 HEATH ST HARTFORD DAGOODCHEF@ICLOUD.COM REQUITED NOISE L.L.C. 101 PEARL ST APT 101 HARTFORD BMURTAGHMUSIC@GMAIL.COM OLIVA ROYAL RENOVATION LLC 79 SUMNER ST HARTFORD OLIVAMARCOS745@GMAIL.COM TAZACT LLC 95 PRATT ST HARTFORD TAZAHARTFORD@GMAIL.COM PATWAH HOLDING AND MANAGEMENT LLC 36 RUSS STREET , 3RD FLOOR #1201 HARTFORD EFILE1234@INCFILE.COM VMA HANDYMAN SERVICES LLC 36 RUSS STREET , 3RD FLOOR #1202 HARTFORD EFILE1234@INCFILE.COM ELLA KERR ENTERPRISE LLC 275 HOLCOMB STREET HARTFORD ELLAKERRENTERPRISE876@GMAIL.COM S & J MART LLC 316 FARMINGTON AVE HARTFORD TASKPK2020@GMAIL.COM KC REGAL RENTALS LLC 36 RUSS STREET , 3RD FLOOR #1207 HARTFORD EFILE1234@INCFILE.COM MI SABOR RESTAURANT LLC 75 PARK STREET HARTFORD ISABEL@MULTISERVICESINTL.COM RICH OFF ROLLING LLC 22 BELDEN ST HARTFORD RICHONWHEELS2025@GMAIL.COM